CD274 and neoplasm: Studies conducted on cancer patients have provided that anti-PD-L1 antibodies exert a therapeutic effect through the expansion of pre-existing tumor-specific T cells and the infiltration of new clonotype T cells, thereby effecting clonal replacement (1, 50, 51).